Wolters Kluwer Health Expands Lippincott Advisor To Help Long-Term Care Facilities Improve Nursing Care Planning

Software Upgrade Helps Long-Term Care Nurses Build Better Resident Care Plans

Wolters Kluwer Health, a leading global provider of information and point-of-care solutions for the healthcare industry, recently announced it has further bolstered the use of Lippincott Advisor in the long-term care (LTC) setting. The company has added a new component to the product designed to help LTC nurses and clinicians develop better resident care plans used to guide treatment. Lippincott Advisor is a leading online clinical decision-support solution used by nurses and clinicians at the bedside in hospitals and healthcare institutions.

A total of 247 LTC nursing care plan entries — one for each of the LTC-specific diseases and conditions included in Lippincott Advisor — will be added by next August. The first 62 entries are available immediately that target 18 disease state categories, including cardiovascular disorders, gastrointestinal disorders, psychiatric disorders and respiratory disorders.

“Acute care nurses are accustomed to using Lippincott Advisor to help them get immediate, trusted answers at the bedside, including information to help build relevant care plans for their patients,” said Judith McCann, MSN, RN, Chief Nurse, Wolters Kluwer Health, Professional & Education. “Now, long-term care facilities and their clinicians can simplify and accelerate the care planning process and individualize residents’ care plans using the latest evidence-based information found in Advisor. Using these care plans will help ensure resident and nurse satisfaction, meet regulatory guidelines and decrease re-admission to hospitals.”

LTC nurses can create a personalized care plan for each resident using evidence-based information and protocols directly from Lippincott Advisor. Clinicians can select a disease matching the resident’s diagnosis and personalize the care plan to match the resident’s symptoms, identify the most effective interventions and set reasonable expected outcomes that match the resident’s abilities. The resulting individualized care plan can be printed or emailed.

Lippincott Advisor includes more than 10,000 collective entries of critical, evidence-based information spanning diseases & treatments, diagnostic tests, drugs, signs & symptoms, nursing care plans, patient education, Core Measures, hospital-acquired conditions, national guidelines and Sentinel Events. Using a proprietary synoptic search, Lippincott Advisor provides immediate, evidence-based answers to clinicians’ most pressing health information questions.

Lippincott Advisor, part of the Lippincott Solutions suite, is available as a group subscription to organizations owning nursing homes and other long-term care environments as well as hospitals and other healthcare facilities. The product is accessible from any Internet-enabled device, including PCs and mobile devices such as iPad and Android tablets. For more information, visit LippincottSolutions.com.

About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health’s market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language, Lexicomp, Lippincott Williams & Wilkins, Medicom, Medi-Span, Medknow, Ovid, Pharmacy OneSource, ProVation Medical and UpToDate.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6B ($4.7B), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).